Search - tctmd.com

Displaying 81 - 100 of 174

Sort: Relevancy | Date

News Opinion CV Team Dispatch

November 2021 News Roundup

L.A. McKeown

November 01, 2021

News Conference News VIVA 2021

Diverting or Swirling, New Blood-Flow Tech Shows Promise for CLTI

L.A. McKeown

October 08, 2021

News Daily News

DCB in Diabetes Show Promising Long-term Outcomes: BASKET-SMALL 2

L.A. McKeown

August 16, 2021

News Opinion CV Team Dispatch

June 2021 News Roundup

L.A. McKeown

June 01, 2021

News Daily News

Dapagliflozin US Cost-effectiveness Data Expose Barriers to HF Care

Shelley Wood

May 27, 2021

News Conference News ACC 2021

Sacubitril/Valsartan Lowers Triglycerides in HFpEF: PARAGON-HF

Yael L. Maxwell

May 16, 2021

News Daily News

Cardiometabolic Diseases Contribute to Bulk of COVID-19 Hospitalizations

Todd Neale

March 04, 2021

News Daily News

Big Drops in LDL Cholesterol With Inclisiran, but US Clinicians Still Await Drug’s Approval

Michael O'Riordan

March 03, 2021

News Features

The Hope Dealers: How Clinicians and New Tech Could End Unnecessary PAD Amputations

L.A. McKeown

December 24, 2020

News Daily News

AHA’s 2020 Top 10: ISCHEMIA, HCM, Early A-fib Intervention, and More

Shelley Wood

December 17, 2020

News Conference News AHA 2020

No Doctor? No Problem: Remote, Pharmacist-Led Intervention Cuts CVD Risk

Michael O'Riordan

November 19, 2020

News Conference News AHA 2020

Sotagliflozin Scores Wins in SCORED and SOLOIST-WHF Trials

Michael O'Riordan

November 17, 2020

News Conference News AHA 2020

FIDELIO-DKD: Finerenone Cuts CV Events in Diabetic Kidney Disease

Todd Neale

November 16, 2020

News Conference News EAS 2020

Inclisiran Effective Across FH Genotypes, as Well as in Primary Prevention

Michael O'Riordan

October 08, 2020

News Daily News

Fewer MACE in Diabetic Patients Taking SGLT2 Inhibitors vs DPP-4 Inhibitors

Shelley Wood

September 30, 2020

News Conference News ESC 2020

EMPEROR-Reduced: Empagliflozin Cuts Hospitalizations, CV Mortality in HFrEF

Michael O'Riordan

August 28, 2020

News Daily News

New Guidance on Use of Diabetes Drugs for CVD Risk Reduction: ACC Experts

Michael O'Riordan

August 06, 2020

News Daily News

LEADER Analysis Reassures on Liraglutide in Diabetic Patients With Heart Failure

Shelley Wood

March 10, 2020

News Daily News

Patient-Level Data Strengthen Rosiglitazone-CV Link: Meta-analysis

Caitlin E. Cox

February 07, 2020

News Daily News

Injectable GLP-1 Agonist Semaglutide Gets CVD Event Reduction Indication

Michael O'Riordan

January 17, 2020

Advertisement

November 2021 News Roundup

Diverting or Swirling, New Blood-Flow Tech Shows Promise for CLTI

DCB in Diabetes Show Promising Long-term Outcomes: BASKET-SMALL 2

June 2021 News Roundup

Dapagliflozin US Cost-effectiveness Data Expose Barriers to HF Care

Sacubitril/Valsartan Lowers Triglycerides in HFpEF: PARAGON-HF

Cardiometabolic Diseases Contribute to Bulk of COVID-19 Hospitalizations

Big Drops in LDL Cholesterol With Inclisiran, but US Clinicians Still Await Drug’s Approval

The Hope Dealers: How Clinicians and New Tech Could End Unnecessary PAD Amputations

AHA’s 2020 Top 10: ISCHEMIA, HCM, Early A-fib Intervention, and More

No Doctor? No Problem: Remote, Pharmacist-Led Intervention Cuts CVD Risk

Sotagliflozin Scores Wins in SCORED and SOLOIST-WHF Trials

FIDELIO-DKD: Finerenone Cuts CV Events in Diabetic Kidney Disease

Inclisiran Effective Across FH Genotypes, as Well as in Primary Prevention

Fewer MACE in Diabetic Patients Taking SGLT2 Inhibitors vs DPP-4 Inhibitors

EMPEROR-Reduced: Empagliflozin Cuts Hospitalizations, CV Mortality in HFrEF

New Guidance on Use of Diabetes Drugs for CVD Risk Reduction: ACC Experts

LEADER Analysis Reassures on Liraglutide in Diabetic Patients With Heart Failure

Patient-Level Data Strengthen Rosiglitazone-CV Link: Meta-analysis

Injectable GLP-1 Agonist Semaglutide Gets CVD Event Reduction Indication

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content